| Literature DB >> 20719717 |
Abstract
Statins are the most widely used lipid-lowering therapy. Among them, the rosuvastatin can be well tolerated and effectively helps to reach LDL-cholesterol goals in primary and secondary cardiovascular prevention. In addition, rosuvastatin reduces triglyceride and high-sensitivity C-reactive protein level and increases high-density lipoprotein (HDL) cholesterol, too. Imaging studies demonstrated that rosuvastatin therapy can not only reduce atherosclerosis progression but might induce its regression too.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20719717 DOI: 10.1556/OH.2010.28937
Source DB: PubMed Journal: Orv Hetil ISSN: 0030-6002 Impact factor: 0.540